Ameriprise’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.31M | Buy |
168,371
+31,529
| +23% | +$1.74M | ﹤0.01% | 1867 |
|
|
2025
Q1 | $6.62M | Sell |
136,842
-4,545
| -3% | -$220K | ﹤0.01% | 2088 |
|
|
2024
Q4 | $5.46M | Sell |
141,387
-2,420
| -2% | -$93.4K | ﹤0.01% | 2291 |
|
|
2024
Q3 | $6.47M | Buy |
+143,807
| New | +$6.47M | ﹤0.01% | 2187 |
|
|
2023
Q3 | – | Sell |
-99,930
| Closed | -$2.76M | – | 3950 |
|
|
2023
Q2 | $2.76M | Buy |
99,930
+81,572
| +444% | +$2.25M | ﹤0.01% | 2714 |
|
|
2023
Q1 | $422K | Buy |
+18,358
| New | +$422K | ﹤0.01% | 3489 |
|
|
2021
Q2 | – | Sell |
-28,488
| Closed | -$737K | – | 3946 |
|
|
2021
Q1 | $737K | Sell |
28,488
-38,367
| -57% | -$993K | ﹤0.01% | 3255 |
|
|
2020
Q4 | $1.35M | Buy |
+66,855
| New | +$1.35M | ﹤0.01% | 2949 |
|